U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H9Cl3N4O2
Molecular Weight 407.638
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DICLAZURIL

SMILES

ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3N=CC(=O)NC3=O

InChI

InChIKey=ZSZFUDFOPOMEET-UHFFFAOYSA-N
InChI=1S/C17H9Cl3N4O2/c18-10-3-1-9(2-4-10)12(7-21)16-13(19)5-11(6-14(16)20)24-17(26)23-15(25)8-22-24/h1-6,8,12H,(H,23,25,26)

HIDE SMILES / InChI
Molecular Formula C17H9Cl3N4O2
Molecular Weight 407.638
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:00:33 UTC 2023
Edited
by admin
on Fri Dec 15 19:00:33 UTC 2023
Record UNII
K110K1B1VE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DICLAZURIL
GREEN BOOK   INN   MART.   MI   USAN   USP   USP-RS  
INN   USAN  
Official Name English
R-64433
Code English
DICLAZURIL [USP MONOGRAPH]
Common Name English
DICLAZURIL [GREEN BOOK]
Common Name English
DICLAZURIL FOR VETERINARY USE
EP  
Common Name English
DICLAZURIL [USP-RS]
Common Name English
NSC-759642
Code English
DICLAZURIL [MART.]
Common Name English
R64,433
Code English
DICLAZURIL [MI]
Common Name English
BENZENEACETONITRILE, 2,6-DICHLORO-.ALPHA.-(4-CHLOROPHENYL)-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN-2(3H)-YL)-
Systematic Name English
R-64-433
Code English
P-64433
Code English
DICLAZURIL [USAN]
Common Name English
NUOQIU
Brand Name English
DICLAZURIL FOR VETERINARY USE [EP MONOGRAPH]
Common Name English
CLINACOX
Brand Name English
(P-CHLOROPHENYL)(2,6-DICHLORO-4-(4,5-DIHYDRO-3,5-DIOXO-AS-TRIAZIN-2(3H)-YL)PHENYL)ACETONITRILE
Common Name English
VECOXAN
Brand Name English
diclazuril [INN]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 520.606
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
CFR 21 CFR 558.198
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
WHO-VATC QP51AJ03
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
NCI_THESAURUS C277
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
CFR 21 CFR 556.185
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
Code System Code Type Description
FDA UNII
K110K1B1VE
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
DAILYMED
K110K1B1VE
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
RXCUI
1368201
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY RxNorm
RS_ITEM_NUM
1188560
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
PUBCHEM
456389
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
MERCK INDEX
m4360
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY Merck Index
ChEMBL
CHEMBL284733
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
INN
5971
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
USAN
Y-61
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
SMS_ID
100000082936
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
CAS
101831-37-2
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
NCI_THESAURUS
C76418
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
DRUG BANK
DB11398
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
WIKIPEDIA
DICLAZURIL
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
MESH
C057884
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
EVMPD
SUB07091MIG
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
NSC
759642
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
EPA CompTox
DTXSID4046787
Created by admin on Fri Dec 15 19:00:33 UTC 2023 , Edited by admin on Fri Dec 15 19:00:33 UTC 2023
PRIMARY
Related Record Type Details
Structure of DICLAZURIL SODIUM
SALT/SOLVATE -> PARENT
Structure of DICLAZURIL, (R)-
ENANTIOMER -> RACEMATE
Structure of DICLAZURIL
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
USP
Structure of DICLAZURIL POTASSIUM
SALT/SOLVATE -> PARENT
Structure of DICLAZURIL
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
EP
Structure of DICLAZURIL, (S)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of 2-(3,5-DICHLORO-4-((RS)-(4-CHLOROPHENYL)CYANOMETHYL)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBOXYLIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 2-(3,5-DICHLORO-4-((4-CHLOROPHENYL)CYANOMETHYL)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBOXAMIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of (4-AMINO-2,6-DICHLOROPHENYL)(4-CHLOROPHENYL)ACETONITRILE
IMPURITY -> PARENT
Specific limit is not given. Any other impurity-0.25% peak area.
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-(3,5-DICHLORO-4-(4-CHLOROBENZOYL)PHENYL)-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 2-(3,5-DICHLORO-4-(4-CHLOROBENZYL)PHENYL)-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of (4-AMINO-2,6-DICHLOROPHENYL)(4-CHLOROPHENYL)ACETONITRILE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 2-(3,5-DICHLORO-4-((RS)-(4-CHLOROPHENYL)CYANOMETHYL)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBOXYLIC ACID
IMPURITY -> PARENT
Specific limit is not given. Any other impurity - 0.25% peak area.
EP
Structure of N,2-BIS(3,5-DICHLORO-4-((4-CHLOROPHENYL)CYANOMETHYL)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBOXAMIDE
IMPURITY -> PARENT
Specific limit is not given. Any other impurity - 0.25% peak area.
EP
Structure of 2-(3,5-DICHLORO-4-(4-CHLOROBENZOYL)PHENYL)-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 1.9
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of (4-CHLOROPHENYL)(2,6-DICHLOROPHENYL)ACETONITRILE
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 1.4; Specific limit not given. Any other impurity-0.25% peak area.
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of (2,6-DICHLORO-4-(3,5-DIOXO-4,5-DIHYDRO-1,2,4-TRIAZIN-2(3H)-YL)PHENYL)(4-HYDROXYPHENYL)ACETONITRILE
IMPURITY -> PARENT
Specific limit is not given. Any other impurity - 0.25% peak area.
EP
Structure of 2-(3,5-DICHLORO-4-(4-CHLOROBENZYL)PHENYL)-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE
IMPURITY -> PARENT
Specific limit is not given. Any other impurity - 0.25% peak area.
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of BUTYL 2-(3,5-DICHLORO-4-((4-CHLOROPHENYL)CYANOMETHYL)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBOXYLATE
IMPURITY -> PARENT
Specific limit is not given. Any other impurity - 0.25% peak area.
EP
Structure of 2-(3,5-DICHLORO-4-((4-CHLOROPHENYL)CYANOMETHYL)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBOXAMIDE
IMPURITY -> PARENT
Specific limit is not given. Any other impurity - 0.25% peak area.
EP
Structure of (4-CHLOROPHENYL)(2,6-DICHLOROPHENYL)ACETONITRILE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
Structure of DICLAZURIL
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966